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Protein-losing enteropathy (PLE) is a rare complication 
after the Fontan operation, which was first reported in 1980 [1, 
2]. A preliminary review of the experience at the Mayo Clinic 
reported that the frequency of PLE after the Fontan operation 
was approximately 10% [3]. PLE can be detected by increased 
alpha-1-antitrypsin concentration in a collected stool sample 
[4]. However, detection of alpha-1 antitrypsin does not show the 
site of protein loss in the intestine. Furthermore, it will not show 
Figure 1. A 18-year-old patient with history of complex congenital heart disease (single ventricle, common atrium and large atrial septal defect), 
who had undergone Glenn and Fontan surgeries 1.5 years ago, was referred for evaluation of possible protein-losing enteropathy by 99m Tc-
UBI scintigraphy. The patient suffered from abdominal ascites, pericardial effusion and unexplained loss of serum albumin. Other causes of 
hypoalbuminemia were excluded accordingly (including renal, hepatic and cardiac causes). Immediately after IV administration of 740 MBq 
(20 mCi) of 99mTc-UBI, dynamic imaging was performed from the abdominopelvic area using a dual-head gamma camera equipped with low-energy 
and high-resolution collimator and Tc-99m photopeak. Early dynamic images (2 s per frame) showed immediate appearance of the tracer in the 
small bowel in the mid-abdominal area (large arrow). The photopenic rim around the mid-abdominal activity is due to ascites (arrows)
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Figure 2. Immediately after the perfusion phase, dynamic images were taken (1 min/frame). The anterior view revealed increased tracer uptake in 
the center of the abdomen again compatible with diffuse small intestine loops location
Figure 3. The patient was asked to collect her fecal matter in a bag during the 24 hours after radiotracer injection. The fecal matter was radioactive 
(arrows) which also confirms the abnormal excretion of the tracer in the gastrointestinal tract
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a positive result when the stomach is the place responsible for 
protein loss [5]. An important advantage of functional imaging 
is the possibility to localize the site of the protein loss. Several 
radiopharmaceuticals such as In-111-transferrin, Tc-99m hu-
man immunoglobulin, Tc-99m dextran, Tc-99m human serum 
albumin (Tc-99m HSA), and Tc-99m methylene diphosphonate 
(Tc-99m MDP) have been used for this purpose [6–8]. Tc-99m 
UBI is an anti-microbial peptide which can be used for detection 
of protein loss in the gastrointestinal tract. Our case showed dif-
fuse protein loss in the small bowel and no localized area could 
be demonstrated, which is compatible with other cases of PLE 
following Fontan operation. Our case showed the potential of 
Tc-99m UBI scintigraphy for detection of PLE. To the extent of 
our knowledge, this is the first report in the medical literature in 
this regard.
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